About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Pennsylvania | 626 Studies

Clinical Trials Prostate CancerPennsylvania

Prostate Cancer Clinical Trials in Pennsylvania

Find 626 clinical trials for prostate cancer near Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 626 trials

CompletedAbiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerThis is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in asymptomatic or mildly symptomatic patients with…NCT00887198·Birmingham, Alabama and 133 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0000 Selenium and Vitamin E in Preventing Prostate CancerRATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer.NCT00006392·Chicago, Illinois and 12 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

CompletedReal-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityThe purpose of this study is to characterize the tolerability profiles of enzalutamide and abiraterone acetate (with prednisone) -with specific focus on central nervous system…NCT02663193·Homewood, Alabama and 19 others

CompletedInfluence of Selenium on Prostate Cancer Related BiomarkersPenn State Milton S.NCT01112449·Hershey, Pennsylvania

WithdrawnTesting the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA MutationsThis phase I/Ib trial studies the side effects and best dose of Hu5F9-G4 (magrolimab) when given in combination with olaparib for the treatment of patients with breast or…NCT05807126·Costa Mesa, California and 4 others

TerminatedEnzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma ExpressionThis phase Ib/II trial studies the safety, side effects, best dose, and effectiveness of ribociclib when given with enzalutamide in treating patients with castrate-resistant…NCT02555189·Ann Arbor, Michigan and 3 others

CompletedToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone.NCT00129142·Homewood, Alabama and 154 others

TerminatedA Study of the Drugs Talazoparib and Temozolomide in Prostate CancerThe purpose of this study is to determine what the safest dose of talazoparib plus temozolomide for participants with metastatic castration resistant prostate cancer.NCT04019327·Basking Ridge, New Jersey and 8 others

TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerThe purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no…NCT00089856·Alabaster, Alabama and 125 others

CompletedS9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy and hormone therapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004001·Scottsdale, Arizona and 15 others

WithdrawnAbemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerThis research is studying two experimental drugs, abemaciclib and atezolizumab, alone and in combination with each other, to learn about the safety and effectiveness of these…NCT04272645·Boston, Massachusetts and 3 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)The purpose of this substudy is to assess the efficacy and safety of ifinatamab deruxtecan (I-DXd), given alone or with other treatments in participants with metastatic…NCT06863272·Los Angeles, California and 81 others

CompletedPROvenge Treatment and Early Cancer TreatmentThe PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer.NCT00779402·Berkeley, California and 17 others

TerminatedPhase II, Dose Finding Study of GTx-758The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.NCT01393119·Glendale, Arizona and 20 others

Active not recruitingA Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPCThe purpose of the study is to determine if the intermittent use of androgen-deprivation therapy (ADT) in participants with metastatic castrate-sensitive prostate cancer (mCSPC)…NCT05884398·Homewood, Alabama and 92 others

CompletedPhase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)This phase Ib trial studies the side effects and best dose of niraparib when given together with radium Ra223 dichloride in treating subjects with prostate cancer that keeps…NCT03076203·Birmingham, Alabama and 5 others

UnknownA Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsPhase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended…NCT04903873·Philadelphia, Pennsylvania and 5 others

UnknownStudying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate CancerRATIONALE: Diagnostic procedures, such as dynamic contrast-enhanced magnetic resonance imaging or DCE-MRI and diffusion-weighted imaging or DWI, may provide images of prostate…NCT01562223·Philadelphia, Pennsylvania

CompletedTechnology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyThis trial performs user testing of a mobile-friendly patient history collection and genetic education tool to improve healthcare providers' understanding of prostate cancer…NCT04447703·New York, New York and 4 others

PreviousPage 9 of 32Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma